Thomas Kassberg
2018
In 2018, Thomas Kassberg earned a total compensation of $1.7M as Chief Business Officer and Executive Vice President at Ultragenyx Pharmaceutical, a 27% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $189,600 |
|---|---|
| Option Awards | $786,718 |
| Salary | $441,340 |
| Stock Awards | $242,150 |
| Other | $32,852 |
| Total | $1,692,660 |
Kassberg received $786.7K in option awards, accounting for 46% of the total pay in 2018.
Kassberg also received $189.6K in non-equity incentive plan, $441.3K in salary, $242.2K in stock awards and $32.9K in other compensation.
Rankings
In 2018, Thomas Kassberg's compensation ranked 6,576th out of 14,244 executives tracked by ExecPay. In other words, Kassberg earned more than 53.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,576 out of 14,244 | 54th |
Division Manufacturing | 2,520 out of 5,765 | 56th |
Major group Chemicals And Allied Products | 943 out of 2,128 | 56th |
Industry group Drugs | 791 out of 1,817 | 57th |
Industry Pharmaceutical Preparations | 618 out of 1,391 | 56th |
Source: SEC filing on April 29, 2020.
Kassberg's colleagues
We found six more compensation records of executives who worked with Thomas Kassberg at Ultragenyx Pharmaceutical in 2018.
2018
Wladimir Hogenhuis
Ultragenyx Pharmaceutical
Chief Operating Officer
2018
Camille Bedrosian
Ultragenyx Pharmaceutical
Chief Medical Officer
2018
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2018
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2018
Karah Parschauer
Ultragenyx Pharmaceutical
General Counsel
2018
John Pinion
Ultragenyx Pharmaceutical